Condition
Transformed Follicular Lymphoma (TFL) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Transformed Follicular Lymphoma (TFL) clinical trials that are recruiting, in South Korea. By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
TC011 (CD19 CAR-T) for relapsed or refractory large B‑cell lymphoma
This will test a CD19-targeted CAR-T therapy called TC011 in adults whose large B‑cell lymphoma has relapsed or not responded after prior treatments.
-
Efficacy and safety of CRC01 for adult patients with large B-cell lymphoma
This study is testing a new CAR-T therapy called CRC01, combined with other medications, to see if it can help adults with hard-to-treat large B-cell lymphoma feel better.
Related topics
Quick answers
How many Transformed Follicular Lymphoma (TFL) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.